Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
5-hydroxytryptamine receptor 2C | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 12 | 1 | 13 |
5-hydroxytryptamine receptor 1B | 0 | 11 | 1 | 12 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 6 | 0 | 0 | 1 | 1 |
Sodium-dependent serotonin transporter | 0 | 8 | 1 | 9 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 5A | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
glucocerebrosidase | 4 | 0 | 0 | 4 |
DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
Atrial natriuretic peptide receptor 3 | 0 | 2 | 0 | 2 |
Type-1A angiotensin II receptor | 0 | 4 | 2 | 6 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Type-1B angiotensin II receptor | 0 | 4 | 0 | 4 |
Type-1 angiotensin II receptor | 0 | 4 | 3 | 9 |
Type-2 angiotensin II receptor | 0 | 4 | 0 | 4 |
Type-2 angiotensin II receptor | 0 | 3 | 0 | 3 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
acetylcholinesterase | 8 | 0 | 0 | 8 |
RAR-related orphan receptor gamma | 11 | 0 | 0 | 11 |
GLI family zinc finger 3 | 15 | 0 | 0 | 15 |
AR protein | 17 | 0 | 0 | 17 |
thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 11 | 0 | 0 | 11 |
glucocorticoid receptor [Homo sapiens] | 14 | 0 | 0 | 14 |
retinoic acid nuclear receptor alpha variant 1 | 10 | 0 | 0 | 10 |
estrogen-related nuclear receptor alpha | 15 | 0 | 0 | 15 |
estrogen nuclear receptor alpha | 18 | 0 | 0 | 18 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 10 | 0 | 0 | 10 |
IDH1 | 8 | 0 | 0 | 8 |
euchromatic histone-lysine N-methyltransferase 2 | 14 | 0 | 0 | 14 |
chromobox protein homolog 1 | 8 | 0 | 0 | 8 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 8 | 0 | 0 | 8 |
thyroid hormone receptor beta isoform 2 | 12 | 0 | 0 | 12 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 13 | 0 | 0 | 13 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
geminin | 10 | 0 | 0 | 10 |
lethal factor (plasmid) | 3 | 0 | 0 | 3 |
lamin isoform A-delta10 | 13 | 0 | 0 | 13 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 0 | 1 |
Urease | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 8 | 1 | 9 |
Spike glycoprotein | 11 | 2 | 2 | 15 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
Egl nine homolog 1 | 0 | 0 | 0 | 1 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
Atrial natriuretic peptide receptor 1 | 0 | 1 | 1 | 2 |
Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
thioredoxin reductase | 8 | 0 | 0 | 8 |
GLS protein | 7 | 0 | 0 | 7 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
Bile salt export pump | 0 | 19 | 0 | 19 |
Beta-2 adrenergic receptor | 0 | 3 | 2 | 5 |
Beta-2 adrenergic receptor | 0 | 1 | 1 | 2 |
ATP-dependent phosphofructokinase | 7 | 0 | 0 | 7 |
pregnane X receptor | 2 | 0 | 0 | 2 |
progesterone receptor | 11 | 0 | 0 | 11 |
farnesoid X nuclear receptor | 7 | 0 | 0 | 7 |
pregnane X nuclear receptor | 11 | 0 | 0 | 11 |
aryl hydrocarbon receptor | 6 | 0 | 0 | 6 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 7 | 0 | 0 | 7 |
nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform a | 5 | 0 | 0 | 5 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 13 | 0 | 13 |
Multidrug resistance-associated protein 4 | 0 | 13 | 0 | 13 |
Voltage-dependent calcium channel gamma-2 subunit | 7 | 0 | 0 | 7 |
Glucocorticoid receptor | 0 | 8 | 2 | 15 |
Glycine receptor subunit alpha-1 | 0 | 8 | 0 | 8 |
Glutamate receptor 2 | 7 | 0 | 0 | 7 |
Glycine receptor subunit beta | 0 | 8 | 0 | 8 |
Glycine receptor subunit alpha-2 | 0 | 8 | 0 | 8 |
Glycine receptor subunit alpha-3 | 0 | 8 | 0 | 8 |
Canalicular multispecific organic anion transporter 1 | 0 | 13 | 0 | 13 |
ORF73 | 0 | 0 | 2 | 2 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 16 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 21 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
ATAD5 protein, partial | 6 | 0 | 0 | 6 |
Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
EWS/FLI fusion protein | 6 | 0 | 0 | 6 |
bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
arylsulfatase A | 6 | 0 | 0 | 6 |
lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase mTOR isoform 1 | 4 | 0 | 0 | 4 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Toll-like receptor 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 9 | 0 | 11 |
5-hydroxytryptamine receptor 4 | 0 | 10 | 0 | 10 |
Potassium channel subfamily K member 2 | 0 | 2 | 0 | 2 |
Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 6 | 0 | 6 |
ATP-dependent translocase ABCB1 | 0 | 8 | 1 | 20 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-2A adrenergic receptor | 0 | 10 | 0 | 10 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 4 | 0 | 4 |
Beta-3 adrenergic receptor | 0 | 2 | 1 | 3 |
D(2) dopamine receptor | 0 | 8 | 0 | 9 |
Alpha-2C adrenergic receptor | 0 | 6 | 0 | 6 |
D(1A) dopamine receptor | 0 | 8 | 0 | 9 |
UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 6 | 0 | 6 |
Alpha-1D adrenergic receptor | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 2A | 0 | 10 | 0 | 10 |
5-hydroxytryptamine receptor 2C | 0 | 10 | 0 | 10 |
D(3) dopamine receptor | 0 | 10 | 0 | 11 |
5-hydroxytryptamine receptor 2B | 0 | 10 | 0 | 10 |
D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
5-hydroxytryptamine receptor 6 | 0 | 8 | 0 | 8 |
Potassium channel subfamily K member 10 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 9 | 0 | 9 |
Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 4 | 0 | 4 |
Multidrug and toxin extrusion protein 1 | 0 | 5 | 0 | 5 |
Ataxin-2 | 9 | 0 | 0 | 9 |
Carbonic anhydrase 1 | 0 | 4 | 0 | 5 |
Carbonic anhydrase 2 | 0 | 5 | 0 | 6 |
Carbonic anhydrase 4 | 0 | 4 | 0 | 5 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 7 | 0 | 0 | 7 |
Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
USP1 protein, partial | 4 | 0 | 0 | 4 |
NFKB1 protein, partial | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
regulator of G-protein signaling 4 | 7 | 0 | 0 | 7 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 6 | 0 | 0 | 6 |
muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit pi | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit beta-1 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit delta | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit beta-3 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit beta-2 | 6 | 0 | 0 | 6 |
GABA theta subunit | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit epsilon | 6 | 0 | 0 | 6 |
Proteasome subunit beta type-11 | 0 | 0 | 0 | 1 |
Fumarate hydratase | 2 | 0 | 0 | 2 |
TDP1 protein | 12 | 0 | 0 | 12 |
Thrombopoietin | 2 | 0 | 0 | 2 |
Smad3 | 5 | 0 | 0 | 5 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 8 | 0 | 0 | 8 |
nuclear receptor subfamily 1, group I, member 3 | 9 | 0 | 0 | 9 |
NADPH oxidase 1 | 0 | 1 | 0 | 1 |
retinoid X nuclear receptor alpha | 8 | 0 | 0 | 8 |
G | 7 | 0 | 0 | 7 |
cytochrome P450 2D6 | 4 | 0 | 0 | 4 |
polyprotein | 2 | 0 | 0 | 2 |
67.9K protein | 5 | 0 | 0 | 5 |
peroxisome proliferator-activated receptor delta | 5 | 0 | 0 | 5 |
peroxisome proliferator activated receptor gamma | 8 | 0 | 0 | 8 |
Snq2p | 0 | 0 | 0 | 2 |
caspase-3 | 1 | 0 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 2 | 0 | 2 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 8 | 0 | 0 | 8 |
Histone H2A.x | 3 | 0 | 0 | 3 |
Caspase-7 | 2 | 0 | 0 | 2 |
Spike glycoprotein | 0 | 2 | 2 | 4 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
vitamin D3 receptor isoform VDRA | 7 | 0 | 0 | 7 |
potassium voltage-gated channel subfamily H member 2 isoform d | 5 | 0 | 0 | 5 |
caspase-3 | 2 | 0 | 0 | 2 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 3 | 0 | 0 | 3 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 5 | 0 | 0 | 5 |
peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
Proteasome subunit alpha type-7 | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Transmembrane protease serine 2 | 0 | 2 | 2 | 4 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 4 | 0 | 4 |
Bile salt export pump | 0 | 4 | 0 | 4 |
Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
Interferon beta | 10 | 0 | 0 | 10 |
HLA class I histocompatibility antigen, B alpha chain | 7 | 0 | 0 | 7 |
Albumin | 0 | 4 | 3 | 7 |
Albumin | 0 | 0 | 1 | 1 |
Major prion protein | 0 | 0 | 2 | 2 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Cellular tumor antigen p53 | 8 | 0 | 0 | 8 |
Major prion protein | 0 | 0 | 1 | 1 |
Integrin beta-3 | 3 | 0 | 0 | 3 |
Cytochrome P450 1A2 | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Procathepsin L | 0 | 3 | 2 | 5 |
Muscarinic acetylcholine receptor M2 | 0 | 5 | 1 | 6 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M1 | 0 | 3 | 0 | 4 |
Muscarinic acetylcholine receptor M3 | 0 | 3 | 0 | 4 |
Muscarinic acetylcholine receptor M4 | 0 | 3 | 0 | 4 |
Integrin alpha-IIb | 3 | 0 | 0 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 3 | 0 | 4 |
Muscarinic acetylcholine receptor M5 | 0 | 5 | 0 | 5 |
Replicase polyprotein 1a | 0 | 2 | 2 | 4 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 3 | 1 | 4 |
Replicase polyprotein 1ab | 0 | 4 | 2 | 6 |
Cytochrome P450 2D6 | 0 | 4 | 1 | 5 |
Muscarinic acetylcholine receptor M2 | 0 | 3 | 0 | 4 |
Muscarinic acetylcholine receptor M1 | 0 | 5 | 2 | 7 |
Cytochrome P450 2C9 | 0 | 7 | 0 | 7 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
D | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
Proteasome subunit beta type-1 | 0 | 0 | 0 | 1 |
Substance-K receptor | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 2 | 0 | 3 |
D(1B) dopamine receptor | 0 | 1 | 0 | 2 |
Adenylate cyclase type 3 | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Histamine H2 receptor | 0 | 6 | 0 | 6 |
D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
Proteasome subunit alpha type-1 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-2 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-4 | 0 | 0 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 4 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-8 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-5 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-4 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-6 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 0 | 0 | 1 |
Trypanothione reductase | 0 | 4 | 0 | 4 |
D(4) dopamine receptor | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 1 | 1 | 2 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 2 | 0 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 4 | 0 | 4 |
Mu-type opioid receptor | 0 | 3 | 1 | 4 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
Adenylate cyclase type 8 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-10 | 0 | 0 | 0 | 1 |
Delta-type opioid receptor | 0 | 3 | 0 | 3 |
Kappa-type opioid receptor | 0 | 3 | 0 | 3 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 5 | 0 | 0 | 5 |
Proteasome subunit beta type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-2 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 4 | 0 | 4 |
Cytochrome P450 2J2 | 0 | 5 | 0 | 5 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-6 | 0 | 0 | 1 | 2 |
D(2) dopamine receptor | 0 | 3 | 0 | 4 |
Calmodulin | 0 | 1 | 2 | 3 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 4 | 0 | 4 |
Adenylate cyclase type 6 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 5 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Aldehyde oxidase | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 4 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Adenylyl cyclase 7 | 0 | 2 | 0 | 2 |
Proteasome subunit alpha-type 8 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 7 | 0 | 0 | 7 |
D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-7 | 0 | 0 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
Angiotensin-converting enzyme 2 | 0 | 2 | 2 | 4 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 7 | 0 | 0 | 7 |
Chain A, Cruzipain | 5 | 0 | 0 | 5 |
SMAD family member 2 | 4 | 0 | 0 | 4 |
SMAD family member 3 | 4 | 0 | 0 | 4 |
STAT3, partial | 0 | 2 | 0 | 2 |
activating transcription factor 6 | 3 | 0 | 0 | 3 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
NPC intracellular cholesterol transporter 1 precursor | 3 | 0 | 0 | 3 |
signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 3 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 3 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 3 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 4 | 0 | 0 | 4 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
interleukin 8 | 2 | 0 | 0 | 2 |
PAX8 | 0 | 0 | 0 | 2 |
PPM1D protein | 2 | 0 | 0 | 2 |
alpha-galactosidase | 3 | 0 | 0 | 3 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 2 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 3 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 4 |
Nuclear receptor ROR-gamma | 3 | 1 | 1 | 5 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 5 | 0 | 5 |
Solute carrier organic anion transporter family member 1B1 | 0 | 7 | 0 | 7 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 10 | 0 | 0 | 10 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 2 | 0 | 3 |
Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 0 | 4 |
Carbonic anhydrase 7 | 0 | 2 | 0 | 3 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 3 | 0 | 4 |
Carbonic anhydrase 13 | 0 | 2 | 0 | 3 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 3 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 1 | 4 |
Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 3 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
Luciferase | 3 | 0 | 0 | 3 |
Parkin | 2 | 0 | 0 | 2 |
pyruvate kinase | 1 | 0 | 0 | 1 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 1 | 0 | 0 | 1 |
Aspartate aminotransferase, cytoplasmic | 0 | 1 | 0 | 1 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Hsf1 protein | 0 | 0 | 1 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
cytochrome P450 2C9 precursor | 4 | 0 | 0 | 4 |
Delta-type opioid receptor | 0 | 3 | 0 | 3 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
endonuclease IV | 2 | 0 | 0 | 2 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 2 | 0 | 2 |
Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 4 | 0 | 0 | 4 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Prostaglandin E synthase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 3 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 2 | 1 | 3 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 3 | 1 | 5 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 3 | 1 | 4 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 2 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Thromboxane A2 receptor | 0 | 1 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Squalene synthase | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
Platelet glycoprotein VI | 0 | 1 | 1 | 3 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Androgen receptor | 0 | 3 | 0 | 3 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
glucokinase regulatory protein | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 2 | 0 | 0 | 2 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Protease | 0 | 2 | 0 | 2 |
cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
Cytochrome P450 2A6 | 0 | 1 | 1 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
luciferase | 0 | 0 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 4 | 0 | 5 |
Solute carrier family 22 member 2 | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 3-like | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 3A | 0 | 1 | 0 | 1 |
huntingtin isoform 2 | 2 | 0 | 0 | 2 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
Multidrug resistance protein 1a | 0 | 0 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
Glycoprotein | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |